It’s been more than ten years since the FDA signed off on the United States’ first biosimilar product, opening up what was ...

Explore how multi-angle light scattering enhances biosimilar analysis by delivering accurate molecular weight and size ...

Aurobindo Pharma's subsidiary receives Health Canada NOC for Dyrupeg, confirming its pegylated filgrastim biosimilar's safety ...

Samsung Bioepis reviews Organon acquisition to boost direct biosimilar sales Samsung Bioepis explores direct sales expansion ...

Aurobindo Pharma said its subsidiary CuraTeQ Biologics has received a Notice of Compliance from Health Canada for its ...

Hyderabad: CuraTeQ Biologics Private Limited, a wholly owned subsidiary of Aurobindo Pharma Limited, has received a Notice of ...

Aurobindo Pharma's subsidiary, CuraTeQ Biologics, has received a Notice of Compliance from Health Canada for its biosimilar Dyrupeg. The regulatory nod confirms the drug meets safety and quality ...

Fresenius Kabi, an Operating Company of Fresenius, and a leading provider of essential medicines and medical technologies, ...

Alvotech (NASDAQ:ALVO) is one of the 12 Stocks that Will Bounce Back According to Wall Street Analysts. On December 31, ...

Pittsburgh-based insurer Highmark is further expanding its drug offerings through CivicaScript and leaning on biosimilars as ...

These products are among the largest oncology biologics expected to lose exclusivity over the next five years.

Samsung Bioepis has begun direct commercialization of Byooviz in Europe. Byooviz is a biosimilar to Lucentis’ (ranibizumab).